Trial Profile
Phase I Trial of Ribociclib in Combination With Everolimus and Dexamethasone in Children and Young Adults With Relapsed Acute Lymphoblastic Leukemia
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Ribociclib (Primary) ; Dexamethasone
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Pharmacokinetics
- 12 Feb 2024 Planned End Date changed from 1 Mar 2024 to 30 Sep 2024.
- 11 Sep 2023 Planned End Date changed from 1 Sep 2023 to 1 Mar 2024.
- 11 Sep 2023 Planned primary completion date changed from 1 Sep 2023 to 1 Dec 2023.